- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | IMAGION BIOSYSTEMS LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
| 02.04. | IMAGION BIOSYSTEMS LIMITED: Suspension from Quotation | 1 | ASX | ||
| 29.02. | IMAGION BIOSYSTEMS LIMITED: Appendix 4E and Preliminary Final Report | - | ASX | ||
| 28.02. | IMAGION BIOSYSTEMS LIMITED: Imagion Business Update | 1 | ASX | ||
| 31.01. | IMAGION BIOSYSTEMS LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | 1 | ASX | ||
| 17.01. | IMAGION BIOSYSTEMS LIMITED: Final Director's Interest Notice - Dr. Isaac Bright | 1 | ASX | ||
| 15.01. | IMAGION BIOSYSTEMS LIMITED: Imagion Announces CEO Departure | 1 | ASX | ||
| 20.12.23 | IMAGION BIOSYSTEMS LIMITED: Dr. Isaac Bright Options, Appendix 3X, Appendix 3Y | - | ASX | ||
| 20.12.23 | IMAGION BIOSYSTEMS LIMITED: Notification regarding unquoted securities - IBX | - | ASX | ||
| 13.12.23 | Imagion Biosystems: Imagion Announces Positive Results from IBI10103 Phase I Study Demonstrating Safety and Clinical Feasibility of Molecular MRI with MagSense® HER2 Imaging Agent | 526 | PR Newswire | MELBOURNE, Australia and SAN DIEGO, Dec. 13, 2023 /PRNewswire/ -- Imagion Biosystems Limited (ASX: IBX) recently announced positive results following completion of the IBI10103 phase I clinical... ► Artikel lesen | |
| 07.12.23 | ASX Health Stocks: Imagion and Microba's positive Phase 1 results; and LGP's first mover advantage in France | 1 | Stockhead | ||
| 05.12.23 | IMAGION BIOSYSTEMS LIMITED: Imagion Announces Positive Results from Phase 1 Study | - | ASX | ||
| 04.12.23 | IMAGION BIOSYSTEMS LIMITED: Notification of cessation of securities - IBX | - | ASX | ||
| 13.11.23 | IMAGION BIOSYSTEMS LIMITED: Results of Meeting | 2 | ASX | ||
| 12.11.23 | IMAGION BIOSYSTEMS LIMITED: EGM Investor Presentation | - | ASX |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PROCEPT BIOROBOTICS | 60,61 | +14,40 % | Earnings call: PROCEPT BioRobotics sees 83% revenue surge in Q1 2024 | ||
| MOBILE-HEALTH NETWORK SOLUTIONS | 21,430 | 0,00 % | Mobile-health Retreats on Opening New Pharmacy | ||
| ATRICURE | 24,810 | +2,86 % | AtriCure Inc reports results for the quarter ended in March - Earnings Summary | ||
| GENEDX | 20,880 | +22,32 % | Pre-market Movers: Cyclacel Pharmaceuticals, Marin Software, GeneDx, Sensata Technologies, Lichen China | INDIANAPOLIS (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.05 A.M. ET).In the Green Cyclacel Pharmaceuticals, Inc. (CYCC) is up... ► Artikel lesen | |
| PROGYNY | 32,280 | 0,00 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
| ADAPTHEALTH | 10,060 | +2,13 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| RXSIGHT | 56,73 | +8,82 % | RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| CVRX | 10,120 | 0,00 % | Pre-market Movers: IMCC, CVRX, TGTX, ROOT, PLTN. | WOONSOCKET (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 09.00 A.M. ET).In the Green IM Cannabis Corp. (IMCC) is up over 36% at $0.86.
TG... ► Artikel lesen | |
| MIMEDX | 7,300 | +18,51 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial Results | Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management... ► Artikel lesen | |
| AGILON HEALTH | 4,955 | 0,00 % | agilon health Reports Fourth Quarter 2023 Results | AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the fourth quarter... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 18,000 | -2,17 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results | Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements... ► Artikel lesen | |
| AGILITI | 10,105 | 0,00 % | DigitalOcean to replace Agiliti in S&P SmallCap Index | ||
| NANO-X IMAGING | 9,150 | 0,00 % | Nano-X Imaging LTD.: Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold | - According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average - Findings... ► Artikel lesen | |
| DOCGO | 3,390 | +0,30 % | Evaluating DocGo: Insights From 8 Financial Analysts | ||
| CASTLE BIOSCIENCES | 22,060 | +4,60 % | Castle Biosciences Inc.: Presentations at EADO Highlight Potential Impact of Castle Biosciences' DecisionDx-Melanoma and DecisionDx-SCC Tests on the Management of Patients with Skin Cancer | If choosing to use a molecular test to rule-out a sentinel lymph node biopsy (SLNB) in patients diagnosed with melanoma, it is important to show that patients foregoing an SLNB have low risk outcomes... ► Artikel lesen |
Das Unternehmen IMAGION BIOSYSTEMS LIMITED kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
